BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33463672)

  • 1. Structural basis of a chemokine heterodimer binding to glycosaminoglycans.
    Sepuru KM; Rajarathnam K
    Biochem J; 2021 Mar; 478(5):1009-1021. PubMed ID: 33463672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin.
    Sepuru KM; Nagarajan B; Desai UR; Rajarathnam K
    J Biol Chem; 2018 Nov; 293(46):17817-17828. PubMed ID: 30257866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.
    Brown AJ; Joseph PR; Sawant KV; Rajarathnam K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil recruitment by chemokines Cxcl1/KC and Cxcl2/MIP2: Role of Cxcr2 activation and glycosaminoglycan interactions.
    Sawant KV; Sepuru KM; Lowry E; Penaranda B; Frevert CW; Garofalo RP; Rajarathnam K
    J Leukoc Biol; 2021 Apr; 109(4):777-791. PubMed ID: 32881070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions.
    Sepuru KM; Nagarajan B; Desai UR; Rajarathnam K
    J Biol Chem; 2016 Sep; 291(39):20539-50. PubMed ID: 27471273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.
    Poluri KM; Joseph PRB; Sawant KV; Rajarathnam K
    J Biol Chem; 2013 Aug; 288(35):25143-25153. PubMed ID: 23864653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and biophysical characterization of CXCL3 chemokine.
    Gulati K; Gangele K; Agarwal N; Jamsandekar M; Kumar D; Poluri KM
    Int J Biol Macromol; 2018 Feb; 107(Pt A):575-584. PubMed ID: 28928065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
    Joseph PR; Mosier PD; Desai UR; Rajarathnam K
    Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil chemoattractant.
    Sawant KV; Sepuru KM; Penaranda B; Lowry E; Garofalo RP; Rajarathnam K
    J Leukoc Biol; 2023 Nov; 114(6):666-671. PubMed ID: 37625009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
    Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
    J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of GAG/MIP-2/CXCR2 interfaces and its functional effects.
    Rajasekaran D; Keeler C; Syed MA; Jones MC; Harrison JK; Wu D; Bhandari V; Hodsdon ME; Lolis EJ
    Biochemistry; 2012 Jul; 51(28):5642-54. PubMed ID: 22686371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
    Joseph PRB; Sawant KV; Rajarathnam K
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges.
    Rajarathnam K; Desai UR
    Front Immunol; 2020; 11():660. PubMed ID: 32391006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
    Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
    Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2019 Oct; 294(43):15650-15661. PubMed ID: 31455633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.
    van Gemst JJ; Kouwenberg M; Rops ALWMM; van Kuppevelt TH; Berden JH; Rabelink TJ; Loeven MA; van der Vlag J
    PLoS One; 2018; 13(9):e0201560. PubMed ID: 30248108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.
    Ravindran A; Sawant KV; Sarmiento J; Navarro J; Rajarathnam K
    J Biol Chem; 2013 Apr; 288(17):12244-52. PubMed ID: 23479735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin.
    Brown AJ; Sepuru KM; Rajarathnam K
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.